Enhancing insulin action: from chemical elements to thiazolidinediones
- PMID: 11383915
- DOI: 10.1007/BF03343858
Enhancing insulin action: from chemical elements to thiazolidinediones
Abstract
Type 2 diabetes is characterized by two fundamental biological defects: a reduced glucose-dependent insulin secretion and an increased resistance to the action of insulin at the level of various target tissues. While the use of agents to improve the insulin secretory activity of the islets of Langerhans has witnessed the flourishing of several new drugs over the years, a much greater difficulty has been experienced in the search for insulin-sensitizing drugs. The aim of this article is to critically review this topic, and to emphasize the importance of providing alternative strategies for the management of Type 2 diabetes.
Similar articles
-
Influence of rosiglitazone treatment on beta-cell function in type 2 diabetes: evidence of an increased ability of glucose to entrain high-frequency insulin pulsatility.J Clin Endocrinol Metab. 2003 Aug;88(8):3794-800. doi: 10.1210/jc.2002-021181. J Clin Endocrinol Metab. 2003. PMID: 12915671 Clinical Trial.
-
[Thiazolidinediones].Journ Annu Diabetol Hotel Dieu. 1999:213-29. Journ Annu Diabetol Hotel Dieu. 1999. PMID: 10732419 Review. French. No abstract available.
-
New oral thiazolidinedione antidiabetic agents act as insulin sensitizers.Diabetes Care. 1992 Aug;15(8):1075-8. doi: 10.2337/diacare.15.8.1075. Diabetes Care. 1992. PMID: 1505314 Review. No abstract available.
-
Current views on the mechanism of action of thiazolidinedione insulin sensitizers.Diabetes Technol Ther. 1999 Fall;1(3):267-75. doi: 10.1089/152091599317189. Diabetes Technol Ther. 1999. PMID: 11475273 Review.
-
[Insulin sensitizer drugs--review].Nihon Rinsho. 2002 Sep;60 Suppl 9:409-15. Nihon Rinsho. 2002. PMID: 12387026 Review. Japanese. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical